Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Gaush Meditech Ltd. ( (HK:2407) ) just unveiled an announcement.
Gaush Meditech Ltd announced that its subsidiary, Gaush Tech Ltd, has received the ISO 13485:2016/EN ISO 13485:2016 Quality Management System Certification for Medical Devices from DEKRA. This certification signifies a robust quality management system, enhancing the company’s compliance with global regulatory standards and supporting its international market expansion.
The most recent analyst rating on (HK:2407) stock is a Buy with a HK$10.50 price target. To see the full list of analyst forecasts on Gaush Meditech Ltd. stock, see the HK:2407 Stock Forecast page.
More about Gaush Meditech Ltd.
Gaush Meditech Ltd, incorporated in the Cayman Islands, operates in the medical device industry. The company focuses on designing, developing, producing, and selling ophthalmic electrophysiology equipment, corneal contact lenses, and fluid collection cassettes for phacoemulsification and vitrectomy surgery systems.
Average Trading Volume: 112,808
Technical Sentiment Signal: Hold
Current Market Cap: HK$1.32B
See more insights into 2407 stock on TipRanks’ Stock Analysis page.